Buy Or Sell: Aurobindo Pharma, LIC Housing Finance On Ajit Mishra's Radar — Check Target Price

Ajit Mishra, senior vice president of research at Religare Broking, has recommended buying shares of Aurobindo Pharma Ltd. and LIC Housing Finance Ltd.

Mishra suggests buying Aurobindo Pharma at current market price with a stop loss of Rs 1,110 and a target of Rs 1,240.

Aurobindo Pharma is a leading pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals and active pharmaceutical ingredients.

The company operates in several therapeutic segments, including antibiotics, antiretrovirals, cardiovascular, gastroenterology, and central nervous system.

Aurobindo Pharma has a strong presence in both domestic and international markets, with a significant portion of its revenue coming from exports.

Mishra also recommended LIC Housing Finance at current market price with a stop loss of Rs 600 and a target of Rs 630.

The firm provides long-term finance to individuals for the purchase or construction of residential properties.

It also offers loans for the repair and renovation of existing homes. LIC Housing Finance operates through a network of offices across India and has a robust portfolio of housing loans, catering to various segments of the population.

Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision.